サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1394007

構造的心疾患の中南米市場の2028年までの予測- 地域別分析- 製品別、施術別、エンドユーザー別

South & Central America Structural Heart Market Forecast to 2028 - Regional Analysis - by Product, Procedure, and End User

出版日
ページ情報
英文 123 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
構造的心疾患の中南米市場の2028年までの予測- 地域別分析- 製品別、施術別、エンドユーザー別
出版日: 2023年10月10日
発行: The Insight Partners
ページ情報: 英文 123 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の構造的心疾患市場は、2023年の7億7,068万米ドルから2028年には11億4,835万米ドルに成長すると予測されています。2023年から2028年までのCAGRは6.9%と推定されます。

心血管疾患患者数の増加とトレーニングプログラムが中南米の構造的心疾患市場に拍車をかける

世界保健機関（WHO）によると、中南米では心血管疾患が死因の第2位を占めています。そのため、心血管疾患をコントロールするために様々な取り組みが行われています。心臓弁膜症は、心不全の最も一般的な原因のひとつになると予想されています。大動脈弁や僧帽弁の変性疾患、三尖弁の機能不全疾患は、重症になると臨床経過が悪化します。構造的心疾患に対する低侵襲的、外科的、カテーテル的介入は最近劇的に増加しています。構造的心疾患は心臓弁手術や経カテーテル治療からなる発展途上の分野であるため、心臓外科医や内科医を対象としたさまざまなトレーニングプログラムが用意されています。過去10年間で、構造的心疾患の発生率が急増しているため、適切な能力を備えた人材を確保するための正式な研修プログラムの開発が必要となっています。トレーニングの構成、期間、範囲はプログラムによって大きく異なります。ほとんどのプログラムでは、経カテーテル的大動脈弁置換術（TAVR）をしっかり学ぶと同時に、心房中隔欠損や心室中隔欠損の閉鎖術、左心房付属器の閉鎖術、先天性心疾患のインターベンションについては、それほど多くはないが、さまざまな経験を積むことができます。TAVR、MitraClip僧帽弁修復システム（Abbott Vascular社製）、左心房付属器閉塞術（LAAO）の出現により、複雑な心血管系疾患を有する患者の治療のために行われる構造的心疾患手術の量は大幅に増加しています。多くの組織では、患者の流入に対応するために、構造的心臓プログラムのための組織化された形式でのサービスと手技の提供を開発してきました。SHDのトレーニングはエキサイティングでやりがいがあり、全体としてやりがいのあるものです。この分野が発展するにつれて、SHDトレーニングの標準化は、患者ケアの最高の質を保証するために非常に重要になってくる。トレーニングから実践への移行を成功させるためには、多くの考慮事項をナビゲートしてくれる指導者を見つけることが最高の財産となります。

中南米の構造的心疾患市場概要

南米および中米の構造的心疾患は、ブラジル、アルゼンチン、その他南米に区分されます。ブラジルは、予測期間中にこの地域で最大の市場シェアを記録すると予想されます。医療ツーリズム部門の隆盛と、最新のヘルスケア製品に関する認識を高めるための政府のイニシアティブの高まりが、中南米の構造的心疾患市場成長の要因となっています。さらに、心血管疾患と高血圧の有病率の上昇が、この地域の構造的心疾患市場の成長を促進しています。

中南米の構造的心疾患市場の収益と2028年までの予測（金額）

中南米の構造的心疾患市場のセグメンテーション

中南米の構造的心疾患市場は、製品、手技、エンドユーザー、国に区分されます。

製品別では、中南米の構造的心疾患市場はオクルーダー、環状形成リング、心臓弁バルーン、その他に区分されます。2022年の中南米の構造的心疾患市場では、オクルーダセグメントが最大シェアを占めています。

手技別に見ると、中南米の構造的心疾患市場は心臓弁狭窄症、心臓弁逆流症、左心房付属器閉鎖不全症に区分されます。2022年の中南米の構造的心疾患市場では、心臓弁狭窄症分野が最大のシェアを占めています。

エンドユーザーに基づき、中南米の構造的心疾患市場は病院、外来手術センター、その他に区分されます。病院セグメントが2022年の中南米の構造的心疾患市場で最大のシェアを占めています。

国別では、中南米の構造的心疾患市場は、ブラジル、アルゼンチン、その他中南米に区分されます。2022年の中南米の構造的心疾患市場はブラジルが独占。

Abbott Laboratories社、Medtronic Plc社、Boston Scientific Corp社、Artivion Inc社、Edwards Lifesciences Corp社、Braile Biomedica Industry, Commerce and Representations Ltd社は、中南米の構造的心疾患市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 中南米の構造的心疾患市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の構造的心疾患市場- 市場情勢

  • PEST分析
    • 中南米のPEST分析
  • 専門家の見解

第5章 中南米の構造的心疾患市場：主要市場力学

  • 市場促進要因
    • 革新的な構造的心疾患サービスの利用可能性
    • 心血管疾患症例の増加とトレーニングプログラム
  • 主な市場抑制要因
    • 手術費用の高さ
    • 構造的心疾患装置に関する厳しい規制
  • 主な市場機会
    • 構造的心疾患における人工知能の利用拡大
  • 今後の動向
    • 構造的心疾患デバイス分野における技術の進歩
  • 影響分析

第6章 構造的心疾患市場：中南米分析

  • 中南米の構造的心疾患市場の収益予測と分析

第7章 中南米の構造的心疾患市場-2028年までの収益と予測：製品別

  • 構造的心疾患の概要
  • 2021年および2028年の製品別市場収益シェア（%）
  • オクルーダー
  • 環状形成リング
  • 心臓弁バルーン
  • その他

第8章 中南米の構造的心疾患市場-2028年までの収益と予測：施術別

  • 2021年および2028年の施術別市場収益シェア（%）
  • 心臓弁狭窄症
  • 心臓弁逆流
  • 左心房付属器閉鎖

第9章 中南米の構造的心疾患市場-2028年までの収益と予測：エンドユーザー別

  • 2021年および2028年のエンドユーザー別市場収益シェア（%）
  • 病院
  • 外来手術センター
  • 心臓センター

第10章 中南米の構造的心疾患市場：2028年までの収益と予測：国別分析

  • 中南米の構造的心疾患市場

第11章 中南米の構造的心疾患市場-業界情勢

  • 成長戦略

第12章 企業プロファイル

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • Artivion Inc
  • Edwards Lifesciences Corp
  • Braile Biomedica Industry, Commerce and Representations Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Brazil South & Central America Structural Heart Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 2. Brazil South & Central America Structural Heart Market, by Procedure - Revenue and forecast to 2028 (USD Million)
  • Table 3. Brazil South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and forecast to 2028 (USD Million)
  • Table 4. Brazil South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and forecast to 2028 (USD Million)
  • Table 5. Brazil South & Central America Structural Heart Market, by End User - Revenue and forecast to 2028 (USD Million)
  • Table 6. Argentina South & Central America Structural Heart Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 7. Argentina South & Central America Structural Heart Market, by Procedure - Revenue and forecast to 2028 (USD Million)
  • Table 8. Argentina South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and forecast to 2028 (USD Million)
  • Table 9. Argentina South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and forecast to 2028 (USD Million)
  • Table 10. Argentina South & Central America Structural Heart Market, by End User - Revenue and forecast to 2028 (USD Million)
  • Table 11. Rest of South & Central America South & Central America Structural Heart Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 12. Rest of South & Central America South & Central America Structural Heart Market, by Procedure - Revenue and forecast to 2028 (USD Million)
  • Table 13. Rest of South & Central America South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and forecast to 2028 (USD Million)
  • Table 14. Rest of South & Central America South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and forecast to 2028 (USD Million)
  • Table 15. Rest of South & Central America South & Central America Structural Heart Market, by End User - Revenue and forecast to 2028 (USD Million)
  • Table 16. Recent Organic Growth Strategies in South & Central America Structural Heart Market
  • Table 17. Glossary of Terms

List Of Figures

  • Figure 1. South & Central America Structural Heart Market Segmentation
  • Figure 2. South & Central America Structural Heart Market, by Country
  • Figure 3. South & Central America Structural Heart Market Overview
  • Figure 4. Occluders Segment Held Largest Share of Product Segment in South & Central America Structural Heart Market
  • Figure 5. South & Central America: PEST Analysis
  • Figure 6. South & Central America Structural Heart Market Experts' Opinion
  • Figure 7. South & Central America Structural Heart Market: Impact Analysis of Drivers and Restraints
  • Figure 8. South & Central America Structural Heart Market - Revenue Forecast and Analysis - 2019-2028
  • Figure 9. South & Central America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • Figure 10. .Occluders: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 11. Annuloplasty Rings: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Heart Valve Balloons: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Others: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. South & Central America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • Figure 15. Heart Valve Stenosis: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Heart Valve Regurgitation: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Left Atrial Appendage Closure: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. South & Central America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • Figure 19. Hospitals: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Ambulatory Surgical Centers: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Cardiac Centers: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. South & Central America: South & Central America Structural Heart Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 23. Brazil South & Central America Structural Heart Market Revenue and Forecast to 2028 (USD Million)
  • Figure 24. Argentina South & Central America Structural Heart Market Revenue and Forecast to 2028 (USD Million)
  • Figure 25. Rest of South & Central America South & Central America Structural Heart Market Revenue and Forecast to 2028 (USD Million)
目次
Product Code: BMIRE00028949

The South & Central America structural heart market is expected to grow from US$ 770.68 million in 2023 to US$ 1,148.35 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2023 to 2028.

Rising Number of Cardiovascular Disease Cases and Training Programs Fuel South & Central America Structural Heart Market

According to the World Health Organization (WHO), cardiovascular diseases are the second leading cause of death South & Central America. Therefore, various initiatives are being taken to control cardiovascular diseases. Heart valve disease is expected to be one of the most common causes of heart failure. Degenerative diseases of aortic and mitral valves, and diseases of dysfunctional tricuspid valves lead to a worse clinical course in severe cases. Minimally invasive, surgical, and catheter-based interventions for structural heart disease have increased dramatically recently. The structural heart is an evolving field consisting of heart valve surgeries and transcatheter procedures; therefore, various training programs are being arranged for cardiac surgeons and physicians. Over the past decade, the burgeoning incidence of structural heart disease has necessitated the development of formal training programs to ensure the appropriate competency of workforces. The structure, length, and scope of training vary greatly between programs. Most programs provide solid exposure on transcatheter aortic valve replacement (TAVR) procedures, simultaneously providing a lesser and variable experience of atrial septal or ventricular septal defect closure, left atrial appendage closure, and congenital heart defect interventions. With the advent of TAVR, the MitraClip mitral valve repair system (Abbott Vascular), and left atrial appendage occlusion (LAAO) procedures, there has been a significant increase in the volume of structural cardiac procedures performed for treating patients with complex cardiovascular conditions. Many organizations have developed services and procedural offerings in an organized format for the structural cardiac program to accommodate the influx of patients. Training in SHD is exciting, challenging, and rewarding overall. As the field evolves, standardization of SHD training becomes extremely important to ensure the best quality of patient care. Finding a mentor to help navigate the numerous considerations outlined can be the best asset to successfully transitioning from training to practice.

South & Central America Structural Heart Market Overview

The South and Central America structural heart is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil is expected to register the largest market share in this region during the forecast period. The flourishing medical tourism sector and growing government initiatives to create awareness about modern healthcare products are the factors contributing to the structural heart market growth in South & Central America. Additionally, the rising prevalence of cardiovascular diseases and hypertension is propelling the structural heart market growth in the region.

South & Central America Structural Heart Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Structural Heart Market Segmentation

The South & Central America structural heart market is segmented into product, procedure, end user, and country.

Based on product, the South & Central America structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the South & Central America structural heart market in 2022.

Based on procedure, the South & Central America structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the South & Central America structural heart market in 2022.

Based on end user, the South & Central America structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the South & Central America structural heart market in 2022.

Based on country, the South & Central America structural heart market is segmented into the Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America structural heart market in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, and Braile Biomedica Industry, Commerce and Representations Ltd are some of the leading companies operating in the South & Central America structural heart market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America structural heart market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South & Central America structural heart market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Structural Heart Market - by Product
    • 1.3.2 South & Central America Structural Heart Market - by Procedure
    • 1.3.3 South & Central America Structural Heart Market - by End User
    • 1.3.4 South & Central America Structural Heart Market - by Country

2. South & Central America Structural Heart Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Structural Heart Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South & Central America PEST Analysis
  • 4.3 Expert's Opinion

5. South & Central America Structural Heart Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Availability of Innovative Structural Heart Services
    • 5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Procedures
    • 5.2.2 Stringent Regulations Regarding Structure Heart Devices
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Use of Artificial Intelligence in Structural Heart
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements in the Field of Structural Heart Devices
  • 5.5 Impact analysis

6. Structural Heart Market - South & Central America Analysis

  • 6.1 South & Central America Structural Heart Market Revenue Forecast and Analysis

7. South & Central America Structural Heart Market - Revenue and Forecast to 2028 - by Product

  • 7.1 Overview
  • 7.2 South & Central America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • 7.3 Occluders
    • 7.3.1 Overview
    • 7.3.2 Occluders: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Annuloplasty Rings
    • 7.4.1 Overview
    • 7.4.2 Annuloplasty Rings: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Heart Valve Balloons
    • 7.5.1 Overview
    • 7.5.2 Heart Valve Balloons: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Structural Heart Market - Revenue and Forecast to 2028 - by Procedure

  • 8.1 Overview
  • 8.2 South & Central America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • 8.3 Heart Valve Stenosis
    • 8.3.1 Overview
    • 8.3.2 Heart Valve Stenosis: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Heart Valve Regurgitation
    • 8.4.1 Overview
    • 8.4.2 Heart Valve Regurgitation: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Left Atrial Appendage Closure
    • 8.5.1 Overview
    • 8.5.2 Left Atrial Appendage Closure: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Structural Heart Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 South & Central America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Cardiac Centers
    • 9.5.1 Overview
    • 9.5.2 Cardiac Centers: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Structural Heart Market - Revenue and Forecast to 2028 -Country Analysis

  • 10.1 South & Central America South & Central America Structural Heart Market
    • 10.1.1 Overview
    • 10.1.2 South & Central America: South & Central America Structural Heart Market, by Country, 2021 & 2028 (%)
      • 10.1.2.1 Brazil: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Brazil: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.3 Brazil: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
        • 10.1.2.1.4 Brazil: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
        • 10.1.2.1.4.1 Brazil: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
        • 10.1.2.1.4.2 Brazil: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
        • 10.1.2.1.5 Brazil: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)
      • 10.1.2.2 Argentina: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Argentina: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.3 Argentina: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
        • 10.1.2.2.4 Argentina: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
        • 10.1.2.2.4.1 Argentina: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
        • 10.1.2.2.4.2 Argentina: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
        • 10.1.2.2.5 Argentina: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)
      • 10.1.2.3 Rest of South & Central America: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Rest of South & Central America: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.3 Rest of South & Central America: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
        • 10.1.2.3.4 Rest of South & Central America: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
        • 10.1.2.3.4.1 Rest of South & Central America: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
        • 10.1.2.3.4.2 Rest of South & Central America: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
        • 10.1.2.3.5 Rest of South & Central America: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)

11. South & Central America Structural Heart Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Boston Scientific Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Artivion Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Edwards Lifesciences Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Braile Biomedica Industry, Commerce and Representations Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms